Registration will start at 16.00hrs
GW Pharmaceuticals (GW) and The Austin Company of UK Ltd (Austin) are pleased to be hosting a tour of the recently constructed manufacturing facility project in Sittingbourne. The project involved a small scale manufacturing facility and the first large scale commercial manufacturing for CBD products in the UK which will be used to support the recently approved Epidiolex® treatment for types of childhood epilepsy.
The facility includes capabilities for Milling, Decarboxylation and Liquid Carbon Dioxide Extraction, including large scale manual handling systems within ATEX zones, all within areas designed to cleanroom standards. Austin worked closely in collaboration with GW Pharmaceuticals, providing a full EPCM services from the initial concept & preliminary design, through to detail design, engineering, procurement, construction and commissioning.
Austin are currently supporting GW Pharmaceutical with SAT ‘s and Commissioning. Subsequently this will follow through to Qualification and Process Validation which has commenced. This is an opportunity to share some of the learnings, challenges and successes on a complex small and large scale manufacturing project combined with a tour of the new facility.
|16:00||Arrivals, Introductions, Tea & Coffee|
|16:30||Overview of the site and development plans (Presentation)|
|19:15||Buffet and Networking|
Please note that all attendees must wear appropriate footwear to permit access to the manufacturing facilities. Numbers will be strictly limited for this visit and all attendees must be registered prior to the event. (Please note it will not be possible to be admitted to Site by Security without pre-booking).